chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Injection site pain; very swollen lymph node for the same arm of vaccination; painful lymph node for the same arm of vaccination; Slightly Feverish; Fatiuge; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Injection site pain), LYMPHADENOPATHY (very swollen lymph node for the same arm of vaccination), LYMPH NODE PAIN (painful lymph node for the same arm of vaccination), PYREXIA (Slightly Feverish) and FATIGUE (Fatiuge) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Nov-2021 at 11:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 16-Nov-2021, the patient experienced INJECTION SITE PAIN (Injection site pain), LYMPHADENOPATHY (very swollen lymph node for the same arm of vaccination), LYMPH NODE PAIN (painful lymph node for the same arm of vaccination), PYREXIA (Slightly Feverish) and FATIGUE (Fatiuge). At the time of the report, INJECTION SITE PAIN (Injection site pain), LYMPHADENOPATHY (very swollen lymph node for the same arm of vaccination), LYMPH NODE PAIN (painful lymph node for the same arm of vaccination) and PYREXIA (Slightly Feverish) was resolving and FATIGUE (Fatiuge) outcome was unknown. Not Provided          No Concomitant medications were provided by the reporter. No Treatment information was reported. This case concerns a 24-year-old female patient with no relevant medical history, who experienced the expected events of Injection Site Pain, Lymphadenopathy, Lymph Node Pain, Pyrexia, and Fatigue. The events occurred 1 day after receiving the third dose of mRNA-1273 Vaccine. The rechallenge was not applicable since only information about the third dose was disclosed. The events are consistent with the current understanding of the mechanism of action of the vaccine. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This case concerns a 24-year-old female patient with no relevant medical history, who experienced the expected events of Injection Site Pain, Lymphadenopathy, Lymph Node Pain, Pyrexia, and Fatigue. The events occurred 1 day after receiving the third dose of mRNA-1273 Vaccine. The rechallenge was not applicable since only information about the third dose was disclosed. The events are consistent with the current understanding of the mechanism of action of the vaccine. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
Pain occurred at the time of the injection. Although there were no signs of redness or swelling, pain in my arm continues now 13 days after injection. It is painful to lift my left arm and I am unable to bear weight. Even pulling my shirt off over my head is painful and almost not possible. Over the counter pain medication helps but pain returns as medication wears off. I am active and continue to move my arm to keep the muscles healthy but I am not able to bear weight on it.
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Systemic: Visual Changes/Disturbances-Medium
3 days post vax pt devel arthralgia & myalgia of all 4 extremities & 2 posterior cervical lymph nodes were noticed they were sl tender
Sore stiff aching for 2 months plus in Lt. shoulder at injection site.
Loud high pitched cry - unusual for this child; Antibiotic given for concurrent otitis.
Fever beginning on night of vaccine, continuing for 2 additional days. Headache and severe earache in right ear. Severely ill and unable to get out of bed for 2 -3 days. Swollen and painful lymphnodes in armpits for about a week after vaccination. Extreme fatigue for around 6 months.  Several days after vaccine, severe rash formed on eyelids and persisted for approximately 7 months.  Patient saw dermatologist, allergist, primary care physicians and tried multiple creams (desonide, ellidel, protopic, etc) and eliminated tomatoes from diet. Creams worked for several days and then rash came back. Finally, after several weeks of freezing temperatures, eyelid rash has cleared up, but rash on face persists.
Localized skin reaction over injection site (left arm) began within 24 hours after injection.  Red, itchy, and swollen.  Lasted 3-4 days.  Vaccine Friday-improving by Monday. Due to the circumstances of vaccination that generated this VAERS report, the vaccine manufacturer, the lot number, the injection site and the providers name and phone number were not available to us.
Feb 5, 2021 at 8:45   started coughing as if having an allergic reaction to a cat.  We stopped and got me some Claritin, cough drops, and water.   Called my PCP and left message.  Coughed an asthmatic cough Friday, Saturday, Sunday and Monday. On Monday, Feb. 8 called PCP again. We had a virtual visit.  He said, it was not an allergic reaction.  He prescribed Prednisone and Alburetol inhaler.  On Thursday Feb . 11 I got a rash all over my body that came and went and I got Hives on the palms of my hands. Virtual visit with  my PCP. He said that he retracted his statement from Monday and evidently I was having a reaction to the Vaccine.  I kept taking the Steroid which I finished on Monday.  The rash and hives bothered me till  Monday. Tuesday and Wednesday rash and hives gone.  On Thursday morning I woke up with a burning pain across my left side of my chest to the backside and pain on my knees.  On Friday the pain was also on the backside of my waist.  It felt like shingles.  Went to see the NP at Dr. office.   They don't think I have shingles.  This is all still a reaction to the vaccine.
Information regarding Flumist (2003-2004 Formula) (influenza virus vaccine, live intranasal (2003-2004 Formula) (influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen) was received from a 47-year old female consumer who experienced fever, chills, body aches, abdominal pain, vomiting and nausea. The patient received a dose on 23-Dec-2003. Medical History: The patient has a past history of sarcoidosis (lung condition (not certain), working diagnosis Sarcoid, total remission). Product Details: Indication for Flumist (2003-2004 Formula) was immunization. Product was administered on 23-Dec-2003. Dose regiment was 1 dose (intranasal). Concomitant Therapy: Concomitant therapy included prednisone, Synthroid (levothyroxine sodium), Lasix (furosemide), multivitamins and Caltrate (calcium carbonate tablet). Event Details: On 23-Dec-2003, within 12-16 hours of receiving Flumist, the patient developed fever, chills, body aches, abdominal pain, vomiting and nausea. At the time of this report, the patient explained that she still was a "a little shaky" due to the symptoms originally reported. No additional information was available at the time of this report.
I had a slight fever that was not above 100 degrees. I also had a terrible cough like rattling. When I was able to break the cough up, the mucus was thick but never discolored. On one occasion I did regurgitate, and it was just thick mucus. I used hot teas of all sorts and gargled with warm salt water. I also used Vicks vapor rub and a form of Mucinex. It was causing my blood pressure to increase so I was not able to take that often. I went to the doctor in December and took a home COVID-19 which was negative. It cleared up and then returned at the end of December. The symptoms were the same except for regurgitation. I went somewhere I felt cold and achy, but the room was not cold. I took a different type of tea and used ginger, cinnamon, and turmeric home remedies. I boiled cloves which helped to loosen it up, but it still was not nice. I would start coughing and that would go on for up to 2 minutes. A piece of peppermint or cinnamon would calm the coughing down. I ended up going back to the doctor because I felt like I had COVID-19. They tested me for COVID-19, Flu, and Pneumonia and all of them were negative. I was advised to treat what was diagnosed as a cold with over-the-counter medications.  continued to take the treatment I was taking and increased my fluid intake. I started to feel better in the last couple of weeks. At one point I could be in mid conversation and the coughing erupted. I did isolate myself for 3 or 4 days. I still have the coughing. It's not as bad. Certain things trigger it. I wear mask around a large group of people. If I get a whiff of a cologne or fragrance, it triggers the cough still. My A1C was elevated during this time but my thyroid function was normal.
This spontaneous report as received from a Registered Nurse refers to a patient of unknown age. On 15-AUG-2014 the patient was vaccinated with an expired dose of MMR II (dose not reported, lot # H014646, expiration date 01-AUG-2014, subcutaneously). No known adverse effects. Additional information is not expected.
Reported to pharmacist- 4 days post: rash with clear blisters turning necrotic-pharmacist viewed lesions active blisters/black tissue-left arm lower. Localized in 1" circle-viewed 8-18-10.
Patient presented to our emergency department for an anaphylactic reaction to a flu vaccination earlier in the day.  Patient received injection around 5pm and began to experience itching and hives around 8pm.  EMS was activated by patient after noting chest tightness and shortness of breath.  She was instructed to call EMS after calling the research nurse line (I'm assuming one her vaccination information sheet).  It is unknown which facility she received her injection at or injection specific information (manufacturer, lot number, etc.).  Patient had noted previous reactions to flu shots though none this severe prior.
28OCT elevated temp 103 x 3 days unable to bring temp down; irritability- 1 wk; diarrhea 3-4 days duration; 25OCT reddened pinpoint rash 7-10 days duration;
LEFT ARM STARTED TO BECOME VERY ITCHY AND RED STARTING ON FEBRUARY 3, 2021, 9 DAYS AFTER THE INJECTION.  IT CONTINUES TO  BE ITCHY AND RED AS OF TODAY, FEBRUARY 5, 2021.
RED RAISED QUARTER SIZED REACTION ON ARM SHORTLY AFTER INJECTION WAS GIVEN. PHARMACIST INFORMED PT TO USE ICE PACK, TAKE IBUPROFEN AND/OR TYLENOL AS DIRECTED. PT CALLED BACK 5/12/15 AND SAID THERE WRE RED STRIATIONS FROM INJECTION SITE DOWN BACK OF ARM. UPPER ARM SORE AND PAINFUL AND NECK PAIN. PAIN HAS SUBSIDED SINCE THE INJECTION WAS GIVEN BUT STILL HAS THE ROUND AREA RAISED AND RED STRIATIONS DOWN ARM. WARM TO TOUCH IS STILL THERE.
This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of expired dose) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of expired dose). On 13-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administration of expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information was provided by the reporter.
This spontaneous report was received from a medical assistant referring to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not provided. On unknown dates, the patients were vaccinated with refrigerated improperly stored doses of ROTATEQ lot number M033338, expiration date 15-APR-2018 (dose and route not reported) for prophylaxis. The vaccines were exposed to a total time in the range 47°F to 77°F (9° C to 25 °C) (15.8°C actual temperature) for 1 hour and 34 minutes. The vaccine doses had previous temperature excursions for a total time in the range 47°F to 77°F (9°C to 25"C ) (17.5C actual temperature) for 6 hours and 20 minutes. The call was placed because of a Digital data logger. No adverse experiences were reported. This is one of several reports received from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1703USA011935: US-009507513-1703USA011934: US-009507513-1703USA006822: US-009507513-1703USA011933:
Per pt report, sore arm, aches, fatigue.  Pt reports that dose #1 cause similar sx's that resolved after 5 days.  Pt was day 2 at the time of this report
She has pain and stiffness where it was given; She has pain and stiffness where it was given; This is a spontaneous report from a contactable consumer (patient). This consumer reported similar events for 2 patients. This is the first of 2 reports.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date were unknown), via an unspecified route of administration on 12Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with Pfizer vaccine yesterday (12Jan2021). She had pain in the area and stiffness on Jan2021 where she was injected. Her husband has stiffness in the area. Outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021035096 same reporter/drug, similar event, different patient
Extreme fatigue; Chills; This is a spontaneous report from a contactable consumer (patient). A 88-year-old female patient started received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, lot/batch number: EL3247), via an unspecified route of administration on the right arm on 19Jan2021 13:30 at SINGLE DOSE for COVID-19 immunization at the hospital. Medical history included haemolytic anaemia, diabetes, had spleen removed (splenectomy) on an unknown date, breast cancer. The patient had allergies with cats, lisinopril, and furosemide. The patient was not pregnant (including at the time of vaccination). Concomitant medications included metformin (METFORMIN), insulin glargine (LANTUS), atorvastatin (ATORVASTATIN), and warfarin (WARFARIN). It was reported that the patient had chills and extreme fatigue from time of vaccination on 19Jan2021 14:30, all the way through the next day of 20Jan2021. The patient just went take a nap from 4:00 to 5:30 PM on 20Jan21 then slept through the alarm until 7:45 PM. The patient was not diagnosed with COVID-19 prior and since vaccination. The patient recovered from the events in Jan2021.
After receiving a Td vaccine the patient's site of reaction was tender for a week and a half, but there was no hematoma. The doctor was not concerned and said there was no reaction.
Sometime just have aches and some pains like in your feet and like in legs may be; Sometimes I have ache and pains like in your feet your legs, and something like that; This is a spontaneous report from a contactable consumer. This was reported by consumer (patient). A patient of an unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown, Expiration date: unknown), via an unspecified rout of administration on 05Aug2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in Aug2021, the patient experienced aches and some pains like in your feet and like in legs may be, sometimes had ache and pains like in feet and reported that "aches and some pains like in your feet and like in legs may be; Sometimes I have ache and pains like in your feet your legs, and something like that  and stated that was just wondering to people sometimes tells, I had a one of your first Covid shot Pfizer and I was, on Thursday and I was wondering the sometime just have aches and some pains like in your feet and like in legs may be. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This spontaneous report was received from a healthcare worker refers to a patient of unknown demography. On 06-FEB-2014, the patient was vaccinated with expired M-M-R II, Lot # 0287AG (Expiry: 01-FEB-2014) subcutaneous dose. No known adverse effects were reported. No further information provided. Additional information has been requested.
Initial report received from a pharmacist on 25 October 2013. A 82-year-old female patient, whose medical history and concomitant medications were not reported, had received a dose of FLUZONE HD (Lot number U4785AA, on left deltoid, route was not reported) on 23-Oct-2013. On 24-Oct-2013, after receiving vaccine the patient bruise at injection, red hives below it, area got larger overnight. Corrective treatment included ice on the bruise and BENADRYL. At the time of reporting, outcome of the event was not recovered. No further relevant information was reported. Documents held by sender: none.
PNEUMOVAX 23 VACCINE - SYRINGE IM LOT:T007790 I received the vaccine at a local pharmacy early Wednesday morning and by Wednesday afternoon my arm was too swollen to move from the top my shoulder to my elbow and there were large red patches. Over the next 3- 4 days the swelling and the redness increased, eventually spreading 2-3 inches  past my elbow. I also ran a fever between 100.5 - 101.0 and experienced fatigue and joint pain. The swelling began to slowly diminish after 4 days and by the following Wednesday was almost gone. The fever was gone by the end of the 5th day. I used Tylenol, aleve, and ice packs to treat the swelling. I also received the FLUAD QUAD 2020-2021 vaccine on the same day in a different arm and experienced no side effects in that arm.
Fever; A spontaneous report was received from a consumer concerning a male patient of unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the event of fever.  The patient's medical history was not reported.  Concomitant products information was not reported.  On  27 Jan 2021, prior to the onset of event, the patient received their first of two planned doses of mRNA-1273 (batch number:09L20A) for prophylaxis of COVID-19 infection.   On 28 Jan 2021 after receiving vaccine the patient experienced the event of fever.  Action taken with mRNA-1273 in response to the event was not provided.   Treatment information was not provided.  On 02 Feb 2021 the outcome of the events  fever was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-047944:Crosslinked (MOD21-018124) US-MODERNATX, INC.-MOD-2021-022474:Crosslinked (MOD21-018124)
Chest pain; This is a spontaneous report from a contactable consumer or other non hcp. A 37-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: FC3180), dose 1 via an unspecified route of administration, administered in Arm Left on 10Aug2021 at 11:00 (Age at vaccination: 37 years) as dose 1, single for covid-19 immunisation. Relevant medical history was reported as None. There were no concomitant medications. Prior vaccinations within 4 weeks were None. The patient experienced chest pain on 16Aug2021 at 02:00. It was reported that chest pain has improved, the first time it was too much. Reporter states the chest pain was off and on, that was her concern. The outcome of the event was recovering.  Follow up (19Aug2021): This is a Follow-up spontaneous report from a contactable consumer.  Follow-up activities closed. No further information is expected. .
Felt warm and ears were ringing - pale in color.  Offered water.  No nausea or vomiting.
On the morning of 11/07/2022, my right arm started to feel sore. I thought it was due to me raking leaves. That evening, the front of my right shoulder would get a pain every time I took a deep breath. That continued until the next morning. I called the clinic help desk. I described my symptoms to the nurse who said she was going to send an ambulance. I was close enough and went to the ER myself. They examined me and found blood clots in my lungs. They then admitted me to the hospital on 11/08/2022. I was in the hospital for three days and was released on 11/10/2022. They prescribed blood thinners, which I am still on now.
Information has been received on 01-MAR-2018 regarding a case in litigation from a lawyer and a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. The patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route during 2014, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent strain of shingles. On or about 07-MAR-2016, the patient was treated at a medical center for blistering vesicular outbreaks that were diagnosed as severe shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Around 2:30 PM on 1/10 I could not stay awake and slept for three hours. The following day, 1/11 I had  the following symptoms: swollen glands, headache, nausea, fatigue, joint pain, a metallic taste in my mouth. Symptoms are the same 1/12
Multiple and frequent Flares; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Multiple and frequent Flares) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced CONDITION AGGRAVATED (Multiple and frequent Flares). At the time of the report, CONDITION AGGRAVATED (Multiple and frequent Flares) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication was reported.  Patient reported no known allergies.  It was unknown if patient was enrolled in COVID-19 vaccine trial.  The reporter causality for the event Multiple and frequent flares with humira was a reasonable possibility. No Treatment medication was reported